# Cardinal Health, Inc. (CAH) Stock Analysis: Steady Growth and a 10% Upside Potential

- Link: https://www.directorstalkinterviews.com/cardinal-health-inc-cah-stock-analysis-steady-growth-and-a-10-upside-potential/4121241099
- Published: 2026-02-23T11:26:14+00:00
- Author: Madison Wilson

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, 
is making waves with its compelling financial performance and promising growth trajectory.
With a market capitalization of $52.81 billion, this medical distribution giant 
continues to be a key component in the healthcare supply chain, serving a wide array
of clients from hospitals to pharmacies across the globe.

The current stock price of Cardinal Health stands at $224.44, a testament to its
robust growth, having navigated within a 52-week range of $123.93 to $227.18. The
stock has shown remarkable resilience, with a modest price change of 0.01% recently,
suggesting stability amidst market volatility.

Investors are particularly interested in Cardinal Health’s valuation metrics, which
indicate a forward P/E ratio of 19.43. Despite the absence of a trailing P/E ratio,
the forward P/E suggests that investors are optimistic about the company’s earnings
potential in the near future. However, the lack of a PEG ratio, Price/Book, Price/
Sales, and EV/EBITDA figures might leave some investors wanting more detailed insights
into the company’s valuation.

A standout in Cardinal Health’s financial performance is its impressive revenue 
growth of 18.80%. This robust growth rate underscores the company’s ability to expand
its market share and enhance its service offerings effectively. While specific net
income figures are not available, the earnings per share (EPS) of 6.96 highlights
the company’s profitability on a per-share basis. Additionally, with a substantial
free cash flow of approximately $5.44 billion, Cardinal Health demonstrates strong
financial health and the capacity to reinvest in its operations or return value 
to shareholders.

Dividend-seeking investors will find Cardinal Health’s dividend yield of 0.91% appealing,
supported by a conservative payout ratio of 29.32%. This suggests that the company
maintains a balanced approach to rewarding shareholders while retaining ample capital
for growth initiatives.

Analyst sentiment towards Cardinal Health is predominantly positive, with 13 buy
ratings and 4 hold ratings, and no sell ratings. This bullish outlook is reinforced
by a target price range of $200.00 to $270.00, with an average target of $247.80,
indicating a potential upside of 10.41% from the current price. Such potential gains
make Cardinal Health an attractive proposition for investors looking for both growth
and stability.

From a technical perspective, the stock’s 50-day and 200-day moving averages of 
$210.34 and $175.74, respectively, suggest a strong upward trend. The Relative Strength
Index (RSI) of 51.39 indicates the stock is neither overbought nor oversold, while
the MACD of 4.11, slightly above the signal line of 4.04, supports the ongoing bullish
momentum.

Cardinal Health’s expansive range of services and products, from pharmaceutical 
distribution to medical and surgical solutions, positions it uniquely in the healthcare
industry. Its strategic operations, coupled with a strong financial base, provide
a solid foundation for future growth. Investors should keep an eye on Cardinal Health,
Inc. as it continues to capitalize on its strengths and navigate the ever-evolving
healthcare landscape.

Share on: